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Abstract
© 2016, Springer Science+Business Media New York.We studied 120 patients with compensated
diabetes  mellitus  type 2  (DM-2).  The inclusion  criterion  was  the  absence of  memory loss
complaints  from the  patient  and/or  his/her  relatives.  The  exclusion  criteria  were  diabetes
decompensation, myocardial infarction and/or stroke in anamnesis, glomerular filtration rate
below 60 ml/min, the presence of proliferative retinopathy, and/or other endocrine diseases. To
diagnose  the  cognitive  decline  (CD)  we  used  Mini-Mental  State  Examination  (MMSE),  the
Montreal Cognitive Assessment (MoCA test), Trail Making Test (parts A and B). 77.5 % patients
with type 2 diabetes out of 120 had moderate CD; 5 % had a significant CD (dementia). The
control group consisted of 50 patients with arterial hypertension, which was comparable with
the  DM-2  group.  In  assessing  the  correlations,  we  found  that  the  CD  in  DM-2  group  is
independent of disease duration and the type of diabetic therapy. We discovered a positive
correlation between the age of patients and the speed of cognitive decline. Comparison of
patients in DM-2 group with the control group showed that results in patients with hypertension
(MMSE, MoCA test) were significantly higher (p < 0.01), and the test time of TMT part A and part
B was significantly lower (p < 0.01) than that in patients with DM-2. The authors believe that the
CD in DM-2 has different pathogenic mechanisms than other complications of type 2 diabetes
mellitus, in particular, the insulin resistance of brain tissue.
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